We are live on
!
Find out more
MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.5B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+9.25%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$12.7B
AUM Growth
–
Cap. Flow
+$12.4B
Cap. Flow
% of AUM
97.73%
Top 10 Holdings %
Top 10 Hldgs %
14.47%
Holding
941
New
941
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$282M |
| 2 |
Zoetis
ZTS
|
+$249M |
| 3 |
Amazon
AMZN
|
+$233M |
| 4 |
Meta Platforms (Facebook)
META
|
+$178M |
| 5 |
S&P Global
SPGI
|
+$161M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.78% |
| 2 | Technology | 16.8% |
| 3 | Consumer Discretionary | 11.26% |
| 4 | Industrials | 9.92% |
| 5 | Communication Services | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DERM
176
DELISTED
Dermira, Inc.
DERM
| $20.3M | 0.16% |
+596,941
| New | +$19.3M |
|
177
Graphic Packaging
GPK
$3.52B
| $20.1M | 0.16% |
+1,544,882
| New | +$20.1M |
|
|
FMSA
178
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
| $19.6M | 0.15% |
+2,804,276
| New | +$29.2M |
|
179
Genpact
G
$6.07B
| $19.5M | 0.15% |
+780,585
| New | +$19M |
|
180
TransUnion
TRU
$15.7B
| $19.2M | 0.15% |
+505,346
| New | +$17.8M |
|
181
GSK
GSK
$103B
| $19M | 0.15% |
+361,122
| New | +$18.3M |
|
182
Align Technology
ALGN
$12.4B
| $18.8M | 0.15% |
+163,718
| New | +$16.5M |
|
183
Acadia Healthcare
ACHC
$2.95B
| $18.7M | 0.15% |
+425,462
| New | +$17.3M |
|
184
Euronet Worldwide
EEFT
$2.93B
| $18.4M | 0.15% |
+213,689
| New | +$16.8M |
|
185
Dentsply Sirona
XRAY
$2.86B
| $18.2M | 0.14% |
+293,595
| New | +$17.7M |
|
|
BLUE
186
DELISTED
bluebird bio
BLUE
| $18M | 0.14% |
+15,275
| New | +$15.6M |
|
187
Becton Dickinson
BDX
$46.9B
| $17.8M | 0.14% |
+99,718
| New | +$17.4M |
|
188
Universal Health Services
UHS
$10.2B
| $17.5M | 0.14% |
+141,016
| New | +$16.7M |
|
189
Carter's
CRI
$1.46B
| $17.5M | 0.14% |
+193,960
| New | +$16.7M |
|
|
NVO
190
Novo Nordisk
NVO
$196B
| $17.4M | 0.14% |
+1,023,836
| New | +$17.8M |
|
191
FTI Consulting
FCN
$4.34B
| $17.3M | 0.14% |
+421,122
| New | +$17.5M |
|
192
Exelixis
EXEL
$14.1B
| $17M | 0.13% |
+771,655
| New | +$15.7M |
|
193
Watsco Inc
WSO
$13.8B
| $16.8M | 0.13% |
+117,450
| New | +$17.6M |
|
194
LCI Industries
LCII
$2.6B
| $16.8M | 0.13% |
+167,562
| New | +$18M |
|
|
TSS
195
DELISTED
Total System Services, Inc.
TSS
| $16.5M | 0.13% |
+311,866
| New | +$16.6M |
|
|
GRA
196
DELISTED
W.R. Grace & Co.
GRA
| $16.4M | 0.13% |
+233,594
| New | +$16.4M |
|
197
Target
TGT
$67.3B
| $16.3M | 0.13% |
+295,948
| New | +$18.4M |
|
|
AET
198
DELISTED
Aetna Inc
AET
| $16.2M | 0.13% |
+126,857
| New | +$15.9M |
|
|
SAVE
199
DELISTED
Spirit Airlines, Inc.
SAVE
| $16.1M | 0.13% |
+304,649
| New | +$16.3M |
|
200
Evolent Health
EVH
$350M
| $16.1M | 0.13% |
+733,762
| New | +$14.1M |
|
Similar funds
TGHSA
PAM
HB
MWA
3SCA
HFCIV
DVC
NAM
Marshall Wace North America's Q1 2017 Portfolio in Review
Q1 2017 is the first quarter with a 13F filing on record for Marshall Wace North America, which disclosed 941 positions worth $12.7B. Its ten largest holdings account for 14% of the portfolio.
Its largest position is T-Mobile US: 4,584,723 shares worth $298M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, followed by Technology and Consumer Discretionary.
- Marshall Wace North America's largest Q1 2017 buy was T-Mobile US: 4,584,723 shares worth $298M.
- Marshall Wace North America's ten largest holdings make up 14% of its $12.7B portfolio in Q1 2017.
- Marshall Wace North America disclosed 941 positions in Q1 2017, its first 13F filing on record.
Based on Marshall Wace North America's 13F filing for Q1 2017, filed 12 May 2017.